CTNNB1 and hepatocellular carcinoma: Conversely, mutations in exon 3 of the CTNNB1 gene are observed in 10–15% of hepatocellular adenoma and are associated with an increased risk of malignant transformation into HCC, with the acquisition of the TERT promoter mutation as a second hit [40].